Dose-attenuated IST and Hetrombopag in Elderly (≥65 Years) Patients With Severe Aplastic Anemia

Clinical trial NCT07010237 · RECRUITING

Trial details

NCT number: NCT07010237
Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Sever Aplastic Anaemia Elderly (People Aged 65 or More)Immunosuppressive Treatment

Start date: 2025-02-01
Primary completion: 2028-12-31
Enrollment: 65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.